Human Investing’s Axogen AXGN Stock Holding History

Human Investing’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-375	Closed	-$7K	–	301
2020 Q4	$7K	Buy	+375	New	+$5.51K	﹤0.01%	237

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Human Investing's AXGN Position: Q1 2021 in Review

Human Investing sold out of Axogen (AXGN) in Q1 2021, closing a stake of 375 shares — an estimated $7K sold.

Human Investing first reported a position in AXGN in Q4 2020 and held it in 1 quarter. The position peaked at $7K in Q4 2020. 123 funds tracked by Wall St. Rank hold AXGN as of Q1 2021.

Human Investing reported no remaining Axogen position as of Q1 2021 after selling out during the quarter.
Human Investing sold 375 Axogen shares in Q1 2021, an estimated $7K.
Human Investing first reported a position in Axogen in Q4 2020 and held it in 1 quarter.
Human Investing's Axogen position peaked at $7K in Q4 2020.
123 funds tracked by Wall St. Rank held Axogen as of Q1 2021.

Based on Human Investing's 13F filing for Q1 2021, filed 5 May 2021.